[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100558218":3},{"organization":4,"armGroups":7,"interventions":18,"overallOfficials":24,"centralContacts":25,"locations":32,"responsibleParty":48,"collaborators":24,"id":50,"slug":51,"hasResults":52,"nctId":53,"briefTitle":54,"officialTitle":54,"acronym":24,"eligibilityCriteria":55,"healthyVolunteers":52,"sex":56,"minAge":57,"maxAge":58,"enrollmentInfo":59,"targetDuration":24,"studyType":62,"phases":63,"briefSummary":65,"conditions":66,"keywords":24,"overallStatus":35,"whyStopped":24,"lastUpdateSubmitDate":69,"lastUpdatePostDateStruct":70,"startDateStruct":73,"completionDateStruct":75,"leadSponsor":77,"locationsCount":78},{"fullName":5,"class":6},"Kaohsiung Medical University Chung-Ho Memorial Hospital","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Miyarisan-BM (Clostridium Butyricum Miyairi) first","EXPERIMENTAL","Miyarisan-BM (Clostridium Butyricum Miyairi) for 1 year, then stopped for 1 year",[13],"Drug: Miyarisan-BM (Clostridium Butyricum Miyairi)",{"label":15,"type":10,"description":16,"interventionNames":17},"Miyarisan-BM (Clostridium Butyricum Miyairi) later","observation for 1 year and then Miyarisan-BM (Clostridium Butyricum Miyairi) for 1 year.",[13],[19],{"type":20,"name":21,"description":22,"armGroupLabels":23,"otherNames":24},"DRUG","Miyarisan-BM (Clostridium Butyricum Miyairi)","probiotics",[9,15],null,[26],{"name":27,"role":28,"phone":29,"phoneExt":30,"email":31},"Yang-Pei Chang, M.D.; MSc.","CONTACT","886-7-2911101","8913","cyp905@gmail.com",[33],{"facility":34,"status":35,"city":36,"state":24,"zip":24,"country":37,"countryCode":38,"cosmosGeoPoint":39,"geoPoint":44,"contacts":45},"Kaohsiung Medical Univeristy Hospital","RECRUITING","Kaohsiung City","Taiwan","TW",{"type":40,"coordinates":41},"Point",[42,43],120.31333,22.61626,{"lat":43,"lon":42},[46],{"name":47,"role":28,"phone":29,"phoneExt":30,"email":31},"Yang-Pei Chang, M.D.; MSc,",{"type":49,"investigatorFullName":24,"investigatorTitle":24,"investigatorAffiliation":24,"oldNameTitle":24,"oldOrganization":24},"SPONSOR","100558218","the-clinical-application-of-clostridium-butyricum-miyairisan-for-motor-and-non-motor-symptoms-in-parkinsons-disease-100558218",false,"NCT06548256","The Clinical Application of Clostridium Butyricum Miyairisan for Motor and Non-motor Symptoms in Parkinson's Disease","Inclusion Criteria:\n\n* Male or female over 20 years old, diagnosed with Parkinson's disease.\n\nExclusion Criteria:\n\n* People with Parkinson's disease Dementia, or Lactose Intolerance","ALL","20 Years","90 Years",{"count":60,"type":61},400,"ESTIMATED","INTERVENTIONAL",[64],"NA","This is an open-label, single-center, non-randomized study to assess the efficacy of Clostridium Butyricum Miyairi on the motor and non-motor symptoms of Parkinson's disease",[67,68],"Clostridium Butyricum Miyairi","Parkinson Disease","2024-08-08",{"date":71,"type":72},"2024-08-12","ACTUAL",{"date":74,"type":72},"2023-10-31",{"date":76,"type":61},"2026-12-31",{"name":5,"class":6},1]